Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Ann Surg. 2020 Sep 1;272(3):481–486. doi: 10.1097/SLA.0000000000004155

Table 2.

Surgical Resection

Eligible (n=102*)

Did Not Reach Surgery 25 (25%)
Patient Refused 2/25 (8%)
Progression of Disease 9/25 (36%)
Symptomatic Deterioration 1/25(4%)
Toxicity 9/25 (36%)
Other 4/25 (16%)

Reached Surgery 77 (75%)
Not Resected Due to Complication 1/77 (1%)
Metastatic Disease 3/77 (4%)
Resected 73/77 (95%)
*

1 patient who stopped treatment secondary to diarrhea was not included in the surgery data.